Palatin Investors Prepared for the Long Haul With Another FSD Drug

Published November 19, 2012

Palatin Investors Prepared For The Long Haul With Another FSD Drug

Filed under: drug treatment news articles

I have no business relationship with any company whose stock is mentioned in this article. (More…) … After so much disappointment, it's hard to keep your faith in drug development programs that are aiming for FDA approval in the treatment of FSD/FSAD.
Read more on Seeking Alpha

Can-Fite BioPharma to Develop a Drug for the Treatment of Sexual Dysfunction

Filed under: drug treatment news articles

During clinical studies conducted with other drugs of the company, patients suffering from sexual dysfunction reported that they returned to normal function following the treatment with the company drugs. … Only post comments relevant to the article …
Read more on Sacramento Bee

Cystic Fibrosis Foundation Therapeutics Announces Million CF Drug …

Filed under: drug treatment news articles

The program's goal is to advance one or more drug candidates into the clinic by the end of the multiyear collaboration. "We are excited to expand our efforts with Pfizer to accelerate the development of more therapies that treat the root cause of CF …
Read more on Sacramento Bee

For Biotech Investors: 5 Orphan Drugs And Their Parent Companies

Filed under: drug treatment news articles

The phase IIb results for their orphan drug etiplirsen showed that the drug was effective in the treatment of Duchenne Muscular Dystrophy with a six-minute walk test and measurement of patients' dystrophin fibers (muscular dystrophy mutates the gene …
Read more on Seeking Alpha